Skip to content

Study on the Effects of Perioperative Contralateral Electroacupuncture on Acute Pain after TKA and Its EEG Mechanisms

Study on the Effects of Perioperative Contralateral Electroacupuncture on Acute Pain after TKA and Its EEG Mechanisms

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025002554
Enrollment
Unknown
Registered
2025-12-27
Start date
2026-01-01
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain

Interventions

Intervention Group:Perioperative Contralateral Electroacupuncture
Control Group:Perioperative Sham Electroacupuncture

Sponsors

Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) Meet Western diagnostic criteria for knee osteoarthritis; 2) Age 60-80 years, any gender; 3) BMI 18-34 kg/m²; 4) ASA class I or II, Kellgren-Lawrence (K-L) grade 3 or 4; 5) Knee varus/valgus <15°; 6) First-time right total knee arthroplasty; 7) Right-handed; 8) Normal cognitive function, able to understand instructions and complete the trial.

Exclusion criteria

Exclusion criteria: Exclusion criteria: 1) Patients with severe cardiovascular or cerebrovascular diseases, pacemakers, chronic obstructive pulmonary disease, and neurological disorders such as stroke, brain trauma, epilepsy, severe anxiety, sleep disorders, or mental disorders; 2) Patients with a history of chronic pain, recent use of hormone-based, antipyretic analgesic, or sedative drugs, or those who have received other treatments that may affect the assessment of pain efficacy. Drop-out/Exclusion criteria: 1) Patients with critical postoperative conditions, or changes in condition requiring emergency treatment or transfer to the intensive care unit, or those who experienced adverse reactions during the perioperative period; 2) Patients with poor compliance and those who did not follow the protocol requirements for the trial. Termination/Withdrawal criteria: 1) New diseases that affect the safety evaluation and events considered by the investigator as requiring the termination of the trial; 2) Other (if the subject withdraws from this study voluntarily, the investigator should inquire and record the reason for withdrawal).

Design outcomes

Primary

MeasureTime frame
Numerical Pain Rating Scale;

Secondary

MeasureTime frame
EEG Parameters (Power Spectral Density, Functional Connectivity, Brain Network Features, Microstate Analysis);Quality of the patient's recovery period;Postoperative Recovery Quality Self-Assessment Scale;24-Item Hamilton Depression Scale;The recovery status of joint function, such as HSS and WOMAC scores, etc.;postoperative complications;

Countries

China

Contacts

Public ContactXu Minglan

Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine

471176951@qq.com15921326587

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026